Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia.

Journal article


Thapaliya, Suresh, Whiskey, Eromona and Firdosi, Mudasir 2024. Effective and safe use of intramuscular clozapine in a patient presenting with catatonia and thrombocytopenia. BMJ Case Reports. 17 (8), p. e260197. https://doi.org/10.1136/bcr-2024-260197
AuthorsThapaliya, Suresh, Whiskey, Eromona and Firdosi, Mudasir
AbstractClozapine is the most effective medication for the management of treatment-resistant schizophrenia and schizoaffective disorder, and its discontinuation can pose significant challenges in treatment. We present a patient with a diagnosis of schizoaffective disorder who was stable on clozapine for a decade until discontinuation due to thrombocytopenia. She experienced a relapse of her illness, presenting with psychotic and catatonic features with poor oral intake and physical health complications requiring a lengthy admission to the hospital. There was a poor response to alternative antipsychotics and a full course of electroconvulsive therapy. Intramuscular (IM) clozapine was initiated due to catatonia and refusal to accept oral medications. After receiving 10 doses of IM clozapine, she started accepting oral clozapine and made a full recovery within a few weeks. The low platelet count was persistent, and a bone marrow biopsy showed results consistent with immune thrombocytopenia being the cause of that low platelet count. [Abstract copyright: © BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.]
KeywordsThrombocytopenia; Clozapine; Catatonia - drug therapy; Antipsychotic agents; Psychotic disorders; Immunology; Psychiatry ; Haematology
Year2024
JournalBMJ Case Reports
Journal citation17 (8), p. e260197
PublisherBMJ Publishing Group
ISSN1757-790X
Digital Object Identifier (DOI)https://doi.org/10.1136/bcr-2024-260197
https://doi.org/17/8/e260197
Official URLhttps://casereports.bmj.com/content/17/8/e260197.long
Publication dates
Online14 Aug 2024
Publication process dates
Accepted03 Aug 2024
Deposited04 Sep 2024
Accepted author manuscript
License
File Access Level
Open
Output statusPublished
Permalink -

https://repository.canterbury.ac.uk/item/98xv8/effective-and-safe-use-of-intramuscular-clozapine-in-a-patient-presenting-with-catatonia-and-thrombocytopenia

Download files


Accepted author manuscript
Firdosi-July-2024.pdf
License: CC BY-NC 4.0
File access level: Open

  • 7
    total views
  • 2
    total downloads
  • 0
    views this month
  • 0
    downloads this month

Export as

Related outputs

Editorial: Prolonged grief disorder: vulnerability and resilience
Margoob, Mushtaq, Firdosi, Mudasir and Katshu, Mohammad Zia Ul Haq 2024. Editorial: Prolonged grief disorder: vulnerability and resilience. Frontiers in Psychiatry. 15, p. 1387937. https://doi.org/10.3389/fpsyt.2024.1387937
Neuroleptic malignant syndrome: a guide for psychiatrists
Wadoo, O., Ouanes, S. and Firdosi, M. 2021. Neuroleptic malignant syndrome: a guide for psychiatrists. BJPsych Advances. 27 (6), pp. 373-382. https://doi.org/10.1192/bja.2020.71
Effect of vitamin D supplementation on outcomes in people with early psychosis
Fiona Gaughran, Dominic Stringer, Gabriella Wojewodka, Sabine Landau, Shubulade Smith, Poonam Gardner-Sood, David Taylor, Harriet Jordan, Eromona Whiskey, Amir Krivoy, Simone Ciufolini, Brendon Stubbs, Cecilia Casetta, Julie Williams, Susan Moore, Lauren Allen, Shanaya Rathod, Andrew Boardman, Rehab Khalifa, Mudasir Firdosi, Philip McGuire, Michael Berk and John McGrath 2021. Effect of vitamin D supplementation on outcomes in people with early psychosis. JAMA Network Open. 4 (12), p. e2140858. https://doi.org/10.1001/jamanetworkopen.2021.40858